Background: Anemia remains a major global public health challenge, particularly in low- and middle-income countries, necessitating safe, affordable, and sustainable therapeutic approaches. M. paradisiaca (plantain/banana) has been widely recognized for its nutritional value and traditional medicinal uses and has recently gained attention for its potential role in anemia prevention through its bioactive constituents and emerging green nanotechnology applications. This review critically evaluates current evidence on M. paradisiaca's nutritional, phytochemical, pharmacological, and green nanotechnology-based potential for anemia prevention and management. Methodology: Available evidence indicates that M. paradisiaca is a rich source of iron, vitamin C, folate, vitamin B6, copper, and diverse phytochemicals, including flavonoids, phenolic acids, tannins, and catechins. These constituents exhibit antioxidant, anti-inflammatory, antimicrobial, and metabolic regulatory activities that may support iron homeostasis, erythropoiesis, and protection against oxidative damage. Results and Discussion: Recent studies have also explored the green synthesis of iron oxide nanoparticles using M. paradisiaca extracts, demonstrating favorable physicochemical properties and potential for biomedical applications. However, evidence supporting their direct application in anemia management remains limited to preclinical investigations. Although the findings are encouraging, most evidence comes from in vitro and animal studies. Variability in plant parts, extraction methods, phytochemical composition, and nanoparticle synthesis protocols limits direct comparison among studies and clinical translation. Conclusion: M. paradisiaca is a promising nutritional resource with multifunctional biological activities that may help prevent and manage anemia. Nevertheless, standardized experimental studies and well-designed clinical trials are required to validate its therapeutic efficacy, particularly for green-synthesized iron oxide nanoparticles.